(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

ANTICORPOS ANTI-HEMOJUVELINA (HJV) PARA TRATAR MIELOFIBROSE

Em AnáliseInvention PatentPCT · US2021032343

Application data

Number

112022022986

Type

Invention Patent

Filing

05/13/2021

Publication

01/17/2023

PCT

US2021032343

Progress at the INPI

  1. Filing05/13/21
  2. Publication
  3. Examination
  4. Allowance
  5. Grant
  6. In force

The application was filed at the INPI on 05/13/2021. It awaits formal examination and publication in the RPI gazette.

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 01/17/2023. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

ABBVIE DEUTSCHLAND GMBH & CO. KG

DE

ABBVIE INC.

US

DISC MEDICINE, INC.

US

See this company's full portfolio

Inventors

A. P. (pessoa física)

DE

B. M. (pessoa física)

DE

B. M. (pessoa física)

US

J. P. (pessoa física)

US

J. Q. (pessoa física)

US

M. B. (pessoa física)

US

S. R. (pessoa física)

US

Technical data

Priority claims

US

63/024,416 · 05/13/2020

US

63/035,649 · 06/05/2020

US

63/047,828 · 07/02/2020

US

63/164,294 · 03/22/2021

Abstract

ANTICORPOS ANTI-HEMOJUVELINA (HJV) PARA TRATAR MIELOFIBROSE. Aspectos do pedido fornecem anticorpos anti-hemojuvelina e métodos para usar os mesmos no tratamento de mielofibrose e/ou condições associadas à mielofibrose.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Notificação de entrada na fase nacional - PCT

#1.3

01/17/2023

RPI 2715

Alteração de dados cadastrais

#1.1

11/22/2022

RPI 2707

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.